Wellington Management Group LLP 13D and 13G filings for Revolution Medicines, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-08 10:52 am Sale |
2024-09-30 | 13G | Revolution Medicines, Inc. RVMD |
Wellington Management Group LLP | 11,401,394 6.830% |
-3,480,692 (-23.39%) |
Filing |
| 2024-02-08 10:17 am Purchase |
2023-12-29 | 13G | Revolution Medicines, Inc. RVMD |
Wellington Management Group LLP | 14,882,086 9.090% |
662,656 (+4.66%) |
Filing |
| 2023-11-09 1:26 pm Purchase |
2023-10-31 | 13G | Revolution Medicines, Inc. RVMD |
Wellington Management Group LLP | 14,219,430 12.990% |
5,345,456 (+60.24%) |
Filing |
| 2023-02-06 2:56 pm Sale |
2022-12-30 | 13G | Revolution Medicines, Inc. RVMD |
Wellington Management Group LLP | 8,873,974 9.990% |
-62,495 (-0.70%) |
Filing |
| 2022-12-09 1:50 pm Purchase |
2022-11-30 | 13G | Revolution Medicines, Inc. RVMD |
Wellington Management Group LLP | 8,936,469 10.060% |
4,425,574 (+98.11%) |
Filing |
| 2022-02-04 09:22 am Purchase |
2021-12-31 | 13G | Revolution Medicines, Inc. RVMD |
Wellington Management Group LLP | 4,510,895 6.120% |
4,510,895 (New Position) |
Filing |